All episodes

Ep. 55: Presentation of the EAN mentorship programme

Ep. 55: Presentation of the EAN mentorship programme

16m 54s

Moderator: Rolf Fronczek (Leiden, The Netherlands)

Guest: David Schreier (Bern, Switzerland), Matthieu Perrenoud (Lausanne, Switzerland)

The EAN mentorship programme is dedicated to helping neurologists in Europe to successfully manage these challenges by facilitating the transition of knowledge and experience across generations of neurologists. Moderator Dr. Rolf Fronczek sits down with Dr. David Schreier and Dr. Matthieu Perrenoud to discuss this programme, as well as their experiences on the Mentorship Task Force.

Ep. 54: EAN Guidelines

Ep. 54: EAN Guidelines

14m 45s

Moderator: Rolf Fronczek (Leiden, The Netherlands)

Guest: Katina Aleksovska (Skopje, North Macedonia)

Dr. Katina Aleksovska joins Dr. Rolf Fronczek in an enlightening discussion about the fundamental aspects of guideline creation and Dr. Aleksovska’s personal experience with the Guideline Production Group (GPG). Gain practical insights into the ins and outs of the process and discover how guideline production unfolds within EAN.

Ep. 53: Prodromal DLB – a new diagnostic entity

Ep. 53: Prodromal DLB – a new diagnostic entity

25m 3s

Moderator: Dag Aarsland (London, United Kingdom)

Guest: Laura Bonanni (Chieti, Italy)

In this episode, specialist Moderator Dag Aarsland is joined by Prof. Laura Bonanni to talk about the understanding of the prodromal in dementia with Lewybodies (DLB), the role of different diagnostic methods and management of prodromal DLB.

Ep. 51: Gut microbiota and neurodegenerative diseases

Ep. 51: Gut microbiota and neurodegenerative diseases

26m 32s

Moderator: Kristian Steen Frederiksen (Copenhagen, Denmark)

Guest: Svetlana Tomic (Osijek, Croatia)

In this second episode, Moderator Kristian Steen Frederiksen is joined by Prof. Svetlana Tomic to talk about gut microbiota in context with neurodegenerative diseases.

Ep. 50: Muscle hyperexcitability complaints

Ep. 50: Muscle hyperexcitability complaints

28m 25s

Moderator: Kristian Steen Frederiksen (Copenhagen, Denmark)

Guest: Lutz Fröhlich (Mannheim, Germany)

The field of dementia and specifically the treatment of Alzheimer´s disease is at the brink of a possible new era in which disease-modifying therapy will become available in the form of anti-bodies directed against beta-amyloid.

Prof. Kristian Steen Frederiksen and Prof. Lutz Fröhlich kick off the June episodes on Dementia and Cognitive Disorderswith discussions on the background and development of anti-bodies directed against beta-amyloid development, status with regards to clinical trials in AD of anti-amyloid anti-body therapy, and challenges and opportunities in clinical practice if anti-amyloid anti-body therapy will...

Ep. 49: EAN-WFN Joint Initiatives

Ep. 49: EAN-WFN Joint Initiatives

32m 26s

Moderator: Thomas Berger (Vienna, Austria)

Guest: Wolfgang Grisold (Vienna, Austria)

Prof. Thomas Berger is joined by Prof. Wolfgang Grisold, the current president of the World Federation of Neurology, to discuss brain health, global neurological topics, and joint initiatives between EAN and the WFN.

Ep. 48: Treatment outcome measures of Pompe’s disease

Ep. 48: Treatment outcome measures of Pompe’s disease

25m 19s

Moderator: Anna Kostera-Pruszczyk (Warsaw, Poland)

Guest: Antonio Toscano (Messina, Italy)

For the final episode of the month on Muscle and Neuro-muscular Junction disorders,     Prof. Pruszczyk discusses Pompe’s Disease with Prof. Antonio Toscano.

Ep. 47: Genetic testing and counseling

Ep. 47: Genetic testing and counseling

27m 36s

Moderator: Anna Kostera-Pruszczyk (Warsaw, Poland)
Guest: Maria J. Molnar (Budapest, Hungary), Massimiliano Filosto (Gussago Brescia, Italy)
For this episode, Anna Kostera-Pruszczyk is joined by Prof. Maria J. Molnar and Prof. Massimiliano Filosto to discuss the Pros and Cons of genetic testing and counselling.

Ep. 46: Dilemmas for myasthenia gravis emerging therapies

Ep. 46: Dilemmas for myasthenia gravis emerging therapies

19m 12s

Moderator: Anna Kostera-Pruszczyk (Warsaw, Poland)
Guest: Nicolas Dubuisson (Brussels, Belgium), Amelia Evoli (Rome, Italy)
In this second episode specialist moderator Prof. Anna Kostera-Pruszczyk is joined by Dr. Nicolas Dubuisson and Prof. Amelia Evoli to discuss dilemmas for myasthenia gravis emerging therapies.